Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells von Fiskus, W, Sharma, S, Shah, B, Portier, B P, Devaraj, S G T, Liu, K, Iyer, S P, Bearss, D, Bhalla, K N

Volltext

WTAP is a novel oncogenic protein in acute myeloid leukemia von Bansal, H, Yihua, Q, Iyer, S P, Ganapathy, S, Proia, D, Penalva, L O, Uren, P J, Suresh, U, Carew, J S, Karnad, A B, Weitman, S, Tomlinson, G E, Rao, M K, Kornblau, S M, Bansal, S

Volltext

Evaluation of the marine algae Ulva fasciata and Sargassum sp. for the biosorption of Cu(II) from aqueous solutions von Karthikeyan, S., Balasubramanian, R., Iyer, C.S.P.

Volltext

Diameter dependence of interwall separation and strain in multiwalled carbon nanotubes probed by X-ray diffraction and Raman scattering studies von Singh, Dilip K., Iyer, P.K., Giri, P.K.

Volltext

A unique aptamer-drug conjugate for targeted therapy of multiple myeloma von Wen, J, Tao, W, Hao, S, Iyer, S P, Zu, Y

Volltext

Blended programmatic assessment for competency-based curricula: Is it the way forward? von Iyer, P

Volltext

Cryptococcal meningitis presenting as sinusitis in a renal transplant recipient von Iyer, S.P., Movva, K., Wiebel, M., Chandrasekar, P., Alangaden, G., Carron, M., Tranchida, P., Revankar, S.G.

Volltext

HEXIM1 induction is mechanistically involved in mediating anti-AML activity of BET protein bromodomain antagonist von Devaraj, S G T, Fiskus, W, Shah, B, Qi, J, Sun, B, Iyer, S P, Sharma, S, Bradner, J E, Bhalla, K N

Volltext

Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells von Fiskus, W, Sharma, S, Shah, B, Portier, B P, Devaraj, S G T, Liu, K, Iyer, S P, Bearss, D, Bhalla, K N

Volltext

Development of methane emission factors for Indian paddy fields and estimation of national methane budget von Gupta, Prabhat K., Gupta, Vandana, Sharma, C., Das, S.N., Purkait, N., Adhya, T.K., Pathak, H., Ramesh, R., Baruah, K.K., Venkatratnam, L., Singh, Gulab, Iyer, C.S.P.

Volltext

IBRUTINIB‐RITUXIMAB AND VENETOCLAX (IRV) FOLLOWED BY RISK‐STRATIFIED R‐HYPERCVAD/MTX IN YOUNG PATIENTS WITH UNTREATED MANTLE CELL LYMPHOMA—PHASE‐II WINDOW‐2 TRIAL von Wang, M. L., Lee, H. J., Fetooh, A., Nair, R., Ok, C. Y., Hill, H. A., Iyer, S. P, Steiner, R. E., Westin, J., Nastoupil, L., Fowler, N., Kanagal‐Shamanna, R., Jelloul, F. Z., Castillo, L. E. Malpica, Liu, Y., Li, Y., Vargas, J., Feng, L., Badillo, M., Spike, T., Thirumurthi, S., Santos, D., Xu, G., Deswal, A., Tang, G., Patel, K. P, Vega, F., Medeiros, L. J., Flowers, C., Jain, P.

Volltext

ACALABRUTINIB WITH RITUXIMAB AS FIRST‐LINE THERAPY FOR OLDER PATIENTS WITH MANTLE CELL LYMPHOMA—A PHASE II CLINICAL TRIAL von Jain, P., Ok, C. y., Fetooh, A., Nastoupil, L., Westin, J., Hill, H. A., Nair, R., Iyer, S. P., Steiner, R. E., Lee, H. J., Ahmed, S., Kanagal‐Shamanna, R., Jelloul, F. Z., Castillo, L. E. Malpica, Liu, Y., Vargas, J., Feng, L., Badillo, M., Thirumurthi, S., Xu, G., Deswal, A., Iliescu, C., Nguyen, V. Q., Tang, G., Patel, K., Vega, F., Medeiros, L. J., Flowers, C., Wang, M. L.

Volltext

From the Desk of the Chairman - Internal Auditing & Assurance Standards Board von Raju Iyer, P.

Volltext

Hardness of Decoding Quantum Stabilizer Codes von Iyer, Pavithran, Poulin, David

Volltext

Possible ecological consequences from the Sethu Samudram Canal Project, India von Rao, D.V. Subba, Rao, K. Srinivasa, Iyer, C.S.P., Chittibabu, P.

Volltext

S262: THE COBALT‐LYM STUDY OF CTX130: A PHASE 1 DOSE ESCALATION STUDY OF CD70‐TARGETED ALLOGENEIC CRISPR‐CAS9–ENGINEERED CAR T CELLS IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) T‐CE... von Iyer, S. P., Sica, R. A., Ho, P. J., Hu, B., Zain, J., Prica, A., Weng, W.‐K., Kim, Y. H., Khodadoust, M. S., Palomba, M. L, Foss, F. M., Tipton, K., Cullingford, E. L., He, Q., Sharma, A., Horwitz, S. M.

Volltext

Adsorption of cadmium and copper by modified kaolinites von Suraj, G., Iyer, C.S.P., Lalithambika, M.

Volltext

Utility of ¹⁸fluoro-deoxyglucose positron emission tomography for prognosis and response assessments in a phase 2 study of romidepsin in patients with relapsed or refractory periph... von Horwitz, S, Coiffier, B, Foss, F, Prince, H M, Sokol, L, Greenwood, M, Caballero, D, Morschhauser, F, Pinter-Brown, L, Iyer, S P, Shustov, A, Nichols, J, Balser, J, Balser, B, Pro, B

Volltext

WTAP is a novel oncogenic protein in acute myeloid leukemia von Bansal, H, Yihua, Q, Iyer, S.P, Ganapathy, S, Proia, D.A, Penalva, L.O, Uren, P.J, Suresh, U, Carew, J.S, Karnad, A.B, Weitman, S, Tomlinson, G.E, Rao, M.K, Kornblau, S.M, Bansal, S

Volltext

A research model—forecasting incident rates from optimized safety program intervention strategies von Iyer, P.S., Haight, J.M., Del Castillo, E., Tink, B.W., Hawkins, P.W.

Volltext